Target intelligence / Profile preview

Pyelonephritis-associated pili (P-fimbriae) (Pap)

Target
Pap
Molecular classification
Bacterial adhesin, Surface protein complex, Chaperone-usher pilus
01

Overview

Bacterial P-fimbriae, also known as Pyelonephritis-associated pili (Pap), are complex proteinaceous appendages found on the surface of uropathogenic Escherichia coli (UPEC) (Wright et al., 2007). They play a pivotal role in the pathogenesis of upper urinary tract infections by mediating the specific attachment of the bacteria to Gal(alpha1-4)Gal-containing glycolipids on the surface of human kidney cells (Dodson et al., 2001; Roberts et al., 1994). This adherence is facilitated by the PapG adhesin located at the tip of the pilus, which recognizes the P-blood group antigen (Dodson et al., 2001). The assembly of these fimbriae is governed by the chaperone-usher pathway, a sophisticated protein secretion and folding system (Pinkner et al., 2006). Targeting P-fimbriae offers a promising non-antibiotic strategy to combat infections, with research focusing on small molecules called pilocides that disrupt pilus assembly or carbohydrate mimetics that block the PapG binding site (Pinkner et al., 2006). By preventing bacterial colonization, these therapeutic approaches aim to reduce the incidence of pyelonephritis and urosepsis while minimizing the risk of developing antimicrobial resistance (Wright et al., 2007; Roberts et al., 1994).

Other names
Pap piliP-piliGal-Gal piliPyelonephritis-associated fimbriae
02

Mechanism of action

Inhibition of the PapG adhesin binding to host Gal(alpha1-4)Gal receptors or disruption of the chaperone-usher assembly pathway (Pinkner et al., 2006; Dodson et al., 2001).

03

Biological functions

Bacterial adhesionHost cell colonizationBiofilm formationPathogenesis
04

Disease associations

Urinary tract infectionPyelonephritisUrosepsis
05

Safety considerations

Target specificityPotential for selection of alternative adhesinsLack of clinical validation in humans
06

Interacting drugs

Pilocides

2 more in the full profile.

07

Biomarkers

P-fimbriated Escherichia coli detectionGal-Gal receptor expression

Beyond the preview

Go deeper on Pyelonephritis-associated pili (P-fimbriae) (Pap).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyelonephritis-associated pili (P-fimbriae) (Pap).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call